Pages that link to "Q33381364"
Jump to navigation
Jump to search
The following pages link to Intensive plasma exchange increases a disintegrin and metalloprotease with thrombospondin motifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failure (Q33381364):
Displaying 50 items.
- Initial resuscitation and management of pediatric septic shock (Q28083003) (← links)
- Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue (Q30276550) (← links)
- Multiple organ failure syndrome in the newborn: morphological and immunohistochemical data (Q30571550) (← links)
- Severe transient ADAMTS13 deficiency in pneumococcal-associated hemolytic uremic syndrome (Q33393302) (← links)
- Plasma exchange therapy for thrombotic microangiopathies (Q33393983) (← links)
- Thrombocytopenia-associated multiple organ failure or severe haemolysis, elevated liver enzymes, low platelet count in a postpartum case (Q33408058) (← links)
- Renal thrombotic microangiopathy in a patient with septic disseminated intravascular coagulation (Q33411744) (← links)
- Use of therapeutic plasma exchange in children with thrombocytopenia-associated multiple organ failure in the Turkish thrombocytopenia-associated multiple organ failure network (Q33416769) (← links)
- VWF excess and ADAMTS13 deficiency: a unifying pathomechanism linking inflammation to thrombosis in DIC, malaria, and TTP. (Q33419324) (← links)
- Thrombocytopenia-Associated Multiple Organ Failure and Acute Kidney Injury (Q33426245) (← links)
- What's new in the diagnosis and pathophysiology of thrombotic thrombocytopenic purpura (Q33428178) (← links)
- Thrombocytopenia-associated multiorgan failure occurring in an infant at the onset of type 1 diabetes successfully treated with fresh frozen plasma (Q33433695) (← links)
- Pediatric Sepsis Biomarker Risk Model-II: Redefining the Pediatric Sepsis Biomarker Risk Model With Septic Shock Phenotype (Q33434503) (← links)
- Pathophysiology of Pediatric Multiple Organ Dysfunction Syndrome (Q33439759) (← links)
- Three Hypothetical Inflammation Pathobiology Phenotypes and Pediatric Sepsis-Induced Multiple Organ Failure Outcome (Q33441000) (← links)
- The prognostic value of ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeats, member 13) deficiency in septic shock patients involves interleukin-6 and is not dependent on disseminated intravascular coagulation (Q33751764) (← links)
- Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis (Q34122035) (← links)
- The efficacy and safety of plasma exchange in patients with sepsis and septic shock: a systematic review and meta-analysis (Q35052920) (← links)
- Therapeutic plasma exchange may improve hemodynamics and organ failure among children with sepsis-induced multiple organ dysfunction syndrome receiving extracorporeal life support (Q35582172) (← links)
- Therapeutic plasma exchange as a strategy to reverse multiple organ dysfunction syndrome in patients receiving extracorporeal life support (Q35586159) (← links)
- Global epidemiology of pediatric severe sepsis: the sepsis prevalence, outcomes, and therapies study (Q35672605) (← links)
- THE ENDOTHELIUM IN SEPSIS. (Q35922159) (← links)
- Preserved Expression of mRNA Coding von Willebrand Factor-Cleaving Protease ADAMTS13 by Selenite and Activated Protein C. (Q38636802) (← links)
- The role of plasmapheresis in critical illness (Q36053839) (← links)
- Daily estimation of the severity of organ dysfunctions in critically ill children by using the PELOD-2 score (Q36060518) (← links)
- Pediatric sepsis: challenges and adjunctive therapies. (Q36728513) (← links)
- Decreased ADAMTS 13 Activity is Associated With Disease Severity and Outcome in Pediatric Severe Sepsis (Q36838015) (← links)
- Could Biomarkers Direct Therapy for the Septic Patient? (Q36852546) (← links)
- Pneumococcal hemolytic uremic syndrome and steroid resistant nephrotic syndrome (Q37119048) (← links)
- Outcomes of previously healthy pediatric patients with fulminant sepsis‐induced multisystem organ failure receiving therapeutic plasma exchange (Q37904925) (← links)
- Therapeutic Apheresis in Children: Special Considerations (Q37978684) (← links)
- Septic shock with multiorgan failure: from conventional apheresis to adsorption therapies. (Q37983637) (← links)
- Therapeutic apheresis in pediatrics: technique adjustments, indications and nonindications, a plasma exchange focus (Q37998979) (← links)
- Randomized controlled trials in therapeutic apheresis. (Q38078306) (← links)
- Role of therapeutic apheresis in infectious and inflammatory diseases: Current knowledge and unanswered questions (Q38263347) (← links)
- Pediatric Multiple Organ Dysfunction Syndrome: Promising Therapies. (Q38751931) (← links)
- Epidemiology and Outcomes of Pediatric Multiple Organ Dysfunction Syndrome (Q38935733) (← links)
- Acute Kidney Injury in Pediatric Severe Sepsis: An Independent Risk Factor for Death and New Disability (Q39500397) (← links)
- Outcomes in necrotizing soft tissue infections treated with therapeutic plasma exchange (Q40305748) (← links)
- Plasma exchange in treatment refractory septic shock : Presentation of a therapeutic add-on strategy (Q40896290) (← links)
- Rationale for Adjunctive Therapies for Pediatric Sepsis Induced Multiple Organ Failure (Q41994903) (← links)
- Daily estimation of the severity of multiple organ dysfunction syndrome in critically ill children (Q42154598) (← links)
- Potential danger of isolated platelet transfusion in patients with dengue infection (Q42331834) (← links)
- A Thought on Possible Pathogenesis of Ebola Viral Hemorrhagic Disease and Potential Treatments: Could it Be Thrombotic Thrombocytopenic Purpura-Like Syndrome? (Q44101029) (← links)
- Therapeutic plasma exchange in the treatment of exertional heat stroke and multiorgan failure (Q44166912) (← links)
- Adjunctive corticosteroid therapy in pediatric severe sepsis: Many unsolved questions* (Q44428240) (← links)
- Therapeutic plasma exchange in the management of sepsis and multiple organ dysfunction syndrome: a report of three cases (Q44541129) (← links)
- Use of therapeutic plasma exchange as a rescue therapy in 2009 pH1N1 influenza A--an associated respiratory failure and hemodynamic shock. (Q44613353) (← links)
- Clinical Trial Opportunities in Transfusion Medicine: Proceedings of a National Heart, Lung, and Blood Institute State-of-the-Science Symposium (Q46573703) (← links)
- Use of Therapeutic Plasma Exchange during Extracorporeal Life Support in Critically Ill Cardiac Children with Thrombocytopenia-Associated Multi-Organ Failure. (Q47154735) (← links)